NA Selank Amidate (N-Acetyl Selank Amidate) record · updated 20h ago
NA Selank Amidate is a modified Selank analog with N-acetylation and C-terminal amidation designed to extend stability, studied for anxiolytic and nootropic effects.
How it works: Anxiolytic heptapeptide (Tuftsin analog)
Development stage
where NA Selank Amidate (N-Acetyl Selank Amidate) sits between preclinical work and regulatory approval- 1CurrentPreclinicalAnimal / in-vitro work
- 2Not reachedPhase 1Safety in humans
- 3Not reachedPhase 2Efficacy signal
- 4Not reachedPhase 3Confirmatory trials
- 5Not reachedApprovedCleared by a regulator
Stage is inferred from the highest trial phase in the indexed corpus. It describes the research record, not a recommendation.
| Study | Type | Year | Summary depth |
|---|---|---|---|
| Selank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal in Rats. Finding39.6% reduction in total index of morphine withdrawal syndrome with Selank at 0.3 mg/kg, p<0.0001. | Animal | 2022 | Full text read0.70 |
| Phenibutan—an Illegal Food Supplement With Psychotropic Effects and Health Risks. FindingOverdoses of phenibut (2-100 g) were reported in 15 of the 17 cases. | review | 2024 | Full text read0.70 |
What people are saying
anecdotal · not evidenceUnverified first-hand accounts from public forums. These are not studies: nobody checked what was taken, whether it was what the label said, or what else was going on. They count for nothing in the evidence grade above and are shown because a reader searching NA Selank Amidate (N-Acetyl Selank Amidate) will meet them anyway, and meeting them next to a graded evidence base is better than meeting them alone.